1. /
  2. Our work /
  3. Projects /
  4. Analysis of changes in age of initiation of illicit drug use in Australia

Analysis of changes in age of initiation of illicit drug use in Australia

Open to students

Research shows that earlier initiation of drug use is associated with a range of adverse outcomes later in life including problematic substance use patterns, the use of other illicit drugs, engaging in risk behaviours, greater involvement in criminal activity and completion of fewer years of education.

The National Drug Strategy Household Survey (NDSHS) is a representative population sample of Australians that asks about illicit drug use. Analyses of the 1998 NDSHS data found that more recent age cohorts (i.e. younger Australians) were significantly more likely to have initiated a range of drugs (including cannabis, amphetamines, heroin and LSD) by 15 years of age and they had a lower mean age of first drug use compared to their older counterparts. The study also found increased recent use of illicit drugs among the younger birth cohorts.

There have been many changes in illicit drug markets in Australia since the late 1990s including increasing prevalence of amphetamine and methamphetamine use and declines in cannabis use across all age cohorts, but most dramatically among the younger birth cohorts.

This project is open to students

View 56 more

Update data and monitor trends

The objective is to update analysis of NDSHS survey data over time (2001 to 2022) to monitor trends in age of initiation and prevalence of illicit drug use by birth cohort over time among Australians.

Project contacts

Student supervisor contacts

Dr Amanda Roxburgh

Dr Amanda Roxburgh

Senior Research Fellow
View profile
Professor Paul Dietze

Professor Paul Dietze

Program Director, Disease Elimination; Professor and Program Leader, National Drug Research Institute (NDRI)
View profile

Project team

Dr Amanda Roxburgh

Dr Amanda Roxburgh

Senior Research Fellow
View profile
Professor Paul Dietze

Professor Paul Dietze

Program Director, Disease Elimination; Professor and Program Leader, National Drug Research Institute (NDRI)
View profile
L3 MEETINGROOM2 0406 Cropped

Why study at Burnet?

When you study at Burnet, you broaden your impact working across our three Institute-wide programs: Disease Elimination; Health Security and Pandemic Preparedness; Maternal, Child and Adolescent Health.

Train with internationally recognised experts in a structured student support system, and gain a holistic research experience along the way.

Study at Burnet.

Broaden your impact

On this page